| Document Date: 2015-05-28 10:17:04
Open Document File Size: 122,43 KBShare Result on Facebook
City Geneva / Grenoble / / Company European Laboratory / / Country Switzerland / France / / / Facility University of Geneva / European Laboratory of Molecular Biology / / IndustryTerm chemical / rapamycin-binding site / chemical rapamycin / / MedicalCondition tumor / cancer / tumors / / NaturalFeature Easter Island / / Organization Faculty of Science / Department of Molecular Biology / National Centre of Competence / University of Geneva / / Person Manoel Prouteau / Christiane Schaffitzel / Robbie Loewith / Taiana Oliveira / / / Position researcher / scientist / professor / co-lead author / group and co-lead author / researcher in the group / / PublishedMedium Molecular Biology / /
SocialTag |
Press release Embargo: May 28, 2015, 12:00 noon US Eastern Time A new tool to study an important anti-cancer and immunosuppressive target Structure explains why protein becomes insensitive to its inhibitor rapamycin